2023-10-25 04:00:22
The Institute of Tissue Regenerative Therapy develops a drug, unique in the world, that allows injured athletes to return to elite sport
He Institute of Tissue Regenerative Therapy (ITRT), located at the Teknon Medical Center in Barcelona, is behind the development of this medicine only one in the world. This private center, which has also managed to cure and regenerate other human tissues such as intervertebral discs, bones and cartilage, has just published the results of his clinical trial in the magazine ‘Orthopaedic Journal of Sports Medicine’. The conclusions to 12 months show an unprecedented degree of regeneration in 100% of the 200 patients treated, with decreased pain and return to sports practice after two months.
The drug is already in the “final stretch” of approval by the Spanish Medicines Agency (Aemps)
With this technique, the ITRT has managed to regenerate, for example, the patellar tendon (in the knee joint) of the footballer Martin Odegaard, who now plays for Arsenal and who was previously at Real Madrid. Also the pilot’s clavicle tendon The days of Pedrosa. “We have brought forward great athletes without the need to operate. They can compete again at same level. But also to many ordinary people. There are many ‘amateur’ people who do sports, because these injuries are very prevalent”, says the medical director of the ITRT, Robert Soler.
This drug is already in the “final stretch” of approval by the Spanish Agency for Medicines and Health Products (Aemps). “As soon as they approve it, in a very short period of time, we can make one technology transfer to the public healthcare so that everyone can benefit,” Dr. Soler highlights. This medicine also opens a way for cases of chronic patients, for which to date there was no treatment.
What does the therapy consist of?
The main objective of the ITRT is promote regenerative medicine and, more specifically, orthobiology, the science that investiga and develops materials and substances for accelerate the healing of bone injuries, muscles, ligaments and tendons from the natural resources of the body of the patient himself. To develop this tendon regeneration drug, doctors obtained mesenchymal stem cells of the bone marrow of each patient. These cells were duly grown in a laboratory for three weeks. They were then applied to each patient in the tendon area or peritendon in outpatient surgery. “The patient walks out of the operating room,” Soler points out. It is also a treatment “all natural”.
One of these patients has been Martha Costa, 61 years old, who had four years with “unbearable” pain in the Achilles tendon. Even though he did “a lot of rehabilitation”, the pain persisted. “I couldn’t walk, I drove everywhere by car. There came a point where I couldn’t even sleep because it hurt when it touched me,” explains Costa. Three weeks before extracting stem cells from the bone marrow of the iliac bone (located in the pelvis), Costa underwent outpatient surgery. She was July 2022. “More than a year later, I feel super good. It has changed my life. Now I can go for a walk”, account.
According to Dr. Soler, the patient’s recovery begins 10 days after surgery ambulatory, “whatever tendon it may be.” After three or four months, there is already a “good improvement in pain.” But the importance of this treatment is that it not only eliminates pain, but also achieves “regenerate” the damaged tendon without consequences, something that “never seen before”, according to this doctor. “This allows for quick incorporation to work and, also, the cure of a pathology that until now was incurable,” he explains.
The incidence of tendon injuries increases significantly with age, weight and sex, and affects more men. Until now, when the tendon was subjected to large volume cyclic loading repeatedly, it was wearing out and reducing the possibility of response of the repair or regeneration mechanism, so that the patient, in the majority of cases, ended up undergoing surgery surgically and had to face a phase of long and complicated rehabilitation.
1698208119
#stem #cell #drug #completely #cures #common #tendon #injuries